Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder

Depress Anxiety. 2008;25(2):172-4. doi: 10.1002/da.20303.

Abstract

We report the case of adolescent male with obsessive-compulsive disorder (OCD) who had an incomplete response to combined cognitive-behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / adverse effects
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Aripiprazole
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Desensitization, Psychologic
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Obsessive-Compulsive Disorder / diagnosis
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / psychology
  • Piperazines / administration & dosage*
  • Piperazines / adverse effects
  • Quinolones / administration & dosage*
  • Quinolones / adverse effects
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Sertraline / administration & dosage
  • Sertraline / adverse effects

Substances

  • Antidepressive Agents
  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Serotonin Uptake Inhibitors
  • Aripiprazole
  • Sertraline